Metraipolis › archive › dc_901d485eeb14

Comparative efficacy and safety of individual short-acting versus long-acting granulocyte colony-stimulating factors, including biosimilars, for primary… — Europe PMC PMID:41952689

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41952689
DOI
10.3389/fonc.2026.1764945
License (as archived)
solo-consultazione
Archived
2026-11-04T01:29:10.735Z
SHA-256 of the archived text
ad7d283edb26bf43a6597c18f3ccad658914c6895825f969f2ca7d8f09a6ed48
Stable URL of this page
https://metraipolis.com/documento/dc_901d485eeb14

How to cite

Comparative efficacy and safety of individual short-acting versus long-acting granulocyte colony-stimulating factors, including biosimilars, for primary… — Europe PMC PMID:41952689 — Europe PMC (en), https://europepmc.org/article/MED/41952689 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_901d485eeb14 (Metraipolis archive dc_901d485eeb14, sha256 ad7d283edb26bf43a6597c18f3ccad658914c6895825f969f2ca7d8f09a6ed48)
BibTeX
@misc{dc901d485eeb14,
  title = {Comparative efficacy and safety of individual short-acting versus long-acting granulocyte colony-stimulating factors, including biosimilars, for primary… — Europe PMC PMID:41952689},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41952689},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_901d485eeb14; sha256 ad7d283edb26bf43a6597c18f3ccad658914c6895825f969f2ca7d8f09a6ed48},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41952689. Agents can read the archived copy with the MCP tool read_document.